Skip to content

Comparison of Helicobacter pylori eradication treatment in children with chronic gastritis with non-eradication treatment of Helicobacter pylori in patients with chronic gastritis

Comparison of Helicobacter pylori eradication treatment in children with chronic gastritis with non-eradication treatment of Helicobacter pylori in patients with chronic gastritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230612058464N1
Enrollment
80
Registered
2023-07-24
Start date
2023-06-14
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter positive chronic gastritis. Generalized abdominal pain

Interventions

Intervention 1: Intervention group: A group of 20 children in such a way that the first 10 days of sequential therapy with S-Omeprazole 2 mg/kg/day in two divided doses and simultaneous Helicobacter p

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 15 Years

Inclusion criteria

Inclusion criteria: Parental consent to participate in the study Patients with no history of stomach cancer in children with Helicobacter pylori positive chronic gastritis, which is positive at the same time as the patient's RUT test, and the patient's history and clinical examination with the patient's endoscopic view and pathology report according to first degree relatives

Exclusion criteria

Exclusion criteria: Lack of parental consent to participate in the study Evidence of ulcers or any other pathology other than chronic gastritis in the stomach, esophagus and duodenum. Functional abdominal pain. Mallet's lymphoma. Hemi-sideroplastic anemia ITP Hiatal hernia Patients with history of stomach cancer in first-degree relatives

Design outcomes

Primary

MeasureTime frame
Regurgitation frequency. Timepoint: before the study and after 2 months and after 4 months of treatment. Method of measurement: number.;Frequent heartburn. Timepoint: before the study and after 2 months and after 4 months of treatment. Method of measurement: number.;Vomiting frequency. Timepoint: before the study and after 2 months and after 4 months of treatment. Method of measurement: number.;Abdominal pain frequency localized poorly. Timepoint: before the study and after 2 months and after 4 months of treatment. Method of measurement: number.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hassan Talakesh

Shahre-kord University of Medical Sciences

talakesh.h@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026